Mri Conditional Dual Chamber Implantable Cardioverter Defibrillator System
2
SRPHC154066-MRI CONDITIONAL DUAL CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SYSTEM WITH APPROPRIATE ATRIAL AND VENTRICULAR PACE / SENSE LEADS WITH DF - 4 CONNECTOR AND OPTION OF DUAL SHOCKING COIL LEADS AND ACCESSORIES.SYSTEM SHOULD HAVE ADVANCED FEATURES FOR THE RELIABLE DETECTION AND MANAGEMENT OF VENTRICULAR TACHYCARDIA AND VENTRICULAR FIBRILLATION INCLUDING FEATURES TO DIFFERENTIATE SUPRA-VENTRICULAR TACHYCARDIA FROM VENTRICULAR TACHYCARDIA AND FEATURES TO AVOID INAPPROPRIATE SHOCKS TIERED THERAPY DELIVERY CHOICE OF ATP PROTOCOLS AND SHOCK ENERGIES AND SHOULD BE CAPABLE OF DELIVERING MAXIMUM ENERGY OF 35J OR MORE AND SHOULD HAVE FEATURES FOR MANAGEMENT OF HIGH DEFIBRILLATION ENERGY REQUIREMENT. CHARGE TIMES SHOULD BE WITHIN CLINICALLY ACCEPTABLE LIMITS THROUGHOUT THE LIFETIME OF THE DEVICE.LEADS SHOULD BE LOW PROFILE AND CHOICE OF BOTH ACTIVE OR PASSIVE FIXATION LEADS SHOULD BE AVAILABLE. SHOULD HAVE FEATURES FOR AUTOMATICALLY ALERTING THE PATIENT IN THE EVENT OF A BATTERY OR LEAD FAULT. DATA STORAGE RETRIEVAL AND DISPLAY SHOULD BE EFFICIENT AND USER FRIENDLY. DATA STORAGE SHOULD INCLUDE EPISODE DETAILS THERAPY DELIVERED AND RESULTS AND ELECTROGRAM STORAGE AND SHOULD BE COMPREHENSIVE. BRADYCARDIA PACING (INCLUDING INDEPENDENTLY PROGRAMMABLE PARAMETERS FOR HIGH OUTPUT FOR POST-SHOCK PACING) SHOULD BE AVAILABLE. WARRANTY TERMS SHOULD BE SPECIFIED CLEARLY ALONG WITH THE QUOTATION. FIRMS SHOULD SUBMIT DETAILED LITERATURE OF THE ITEM IN A BULLETIN/TUTORIAL FORMAT WHICH SHOULD CONTAIN ALL THE DETAILS ABOUT THE PRODUCT. COMPLIANCE STATEMENT OF EACH SPECIFICATION TO BE SUBMITTED. THE FIRM QUOTING THE TENDER SHOULD SUBMIT A LETTER OF AUTHORISATION FROM THE PRINCIPAL FIRM/ORIGINAL EQUIPMENT MANUFACTURER. THE MANUFACTURER / SUPPLIER SHOULD SUBMIT PROOF OF SUPPLY TO A MAJOR GOVERNMENT INSTITUTE. THE SAFETY AND EFFICACY OF THE ICD DEVICE AND THE LEAD IN CLINICAL USE SHOULD BE DOCUMENTED IN SCIENTIFIC PUBLICATIONS. ALL THE ABOVE MENTIONED SPECIFICATIONS ARE ESSENTIAL AND MANDATORY AND SHOULD BE SUBMITTED AT THE TIME OF INITIAL TENDER SUBMISSION. UNIT:NO[Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 lacs ] ]ACHD/Surg.Store/RH/PER, SR chennai Tamil Nadu 5.00
3
SRPHC154061-MRI CONDITIONAL SINGLE CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SYSTEM WITH DF - 4 LEAD WITH OTHER ACCESSORIES FOR DETECTION AND MANAGEMENT OF TACHYCARDIA (VT/VF), THERAPY AND FOR BRADYCARDIA THERAPY WITH VENTRICULAR PACING AND ANTI-TACHYCARDIA PACING. IT SHOULD BE CAPABLE OF DELIVERING MAXIMUM ENERGY OF 35 J OR MORE WITH ACCEPTABLE LIMITS THROUGHOUT THE LIFETIME OF THE DEVICE. IT SHOULD AUTOMATICALLY ALERT THE PATIENT IN THE EVENT OF BATTERY OR LEAD FAULT. DATA STORAGE, RETRIEVAL AND DISPLAY SHOULD BE EFFICIENT AND USER FRIENDLY. DATA STORAGE SHOULD INCLUDE EPISODE DETAILS, THERAPY DELIVERED AND RESULTS AND ELECTROGRAM STORAGE AND SHOULD BE COMPREHENSIVE. BRADYCARDIA PACING (INCLUDING INDEPENDENTLY PROGRAMMABLE PARAMETERS FOR HIGH OUTPUT FOR POST SHOCK PACING) SHOULD BE AVAILABLE. WARRANTY TERMS SHOULD BE SPECIFIED CLEARLY ALONG WITH THE QUOTATION. FIRMS SHOULD SUBMIT DETAILED LITERATURE OF THE ITEM IN A BULLETIN/TUTORIAL FORMAT WHICH SHOULD CONTAIN ALL THE DETAILS ABOUT THE PRODUCT. COMPLIANCE STATEMENT OF EACHSPECIFICATION TO BE SUBMITTED. THE SAFETY AND EFFICACY OF THE ICD SYSTEM IN CLINICAL USE SHOULD BE DOCUMENTED IN SCIENTIFIC PUBLICATIONS. THE FIRM QUOTING THE TENDER SHOULD SUBMIT A LETTER OF AUTHORISATION FROM THE PRINCIPAL FIRM/ORIGINAL EQUIPMENT MANUFACTURER. THE MANUFACTURER/SUPPLIER SHOULD SUBMIT PROOF OF SUPPLY OF THE ITEM TO MAJOR GOVERNMENTINSTITUTES. THE SYSTEM SHOULD BE APPROVED BY DCGI AND A COPY OF DCGI APPROVAL SHOULD BE ENCLOSED. ALL THE ABOVE MENTIONED SPECIFICATIONS ARE ESSENTIAL AND MANDATORY AND SHOULD BE SUBMITTED AT THE TIME OF INITIAL TENDER SUBMISSION. UNIT:NO ]ACHD/Surg.Store/RH/PER, SR chennai Tamil Nadu 8.00
We takes all possible care for accurate & authentic tender information, however Users
are requested to refer Original source of Tender Notice / Tender Document published by
Tender Issuing Agency before taking any call regarding this tender.
